Glaxosmithkline Pharmaceuticals Ltd Q4 FY2024-2025 Results: Summary

Revenue
₹1,015.05Cr
Net Profits
₹262.87Cr
Net Profit Margins
25.90%
Highlights
Revenue:

Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 5.51% since last year same period to ₹1,015.05Cr in the Q4 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 3.1% jump in its revenue since last 3-months.

Net Profits:

Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 35.17% since last year same period to ₹262.87Cr in the Q4 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 14.35% jump in its net profits since last 3-months.

Net Profit Margins:

Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 28.11% since last year same period to 25.90% in the Q4 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 10.91% jumped in its net profit margins since last 3-months.

FAQs

What was the revenue for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2024?

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was ₹1,015.05Cr.

What was the net profit for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2024?

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was ₹262.87Cr.

What was the net profit margin for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2024?

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was 25.90%.

What was the revenue for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2023?

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was ₹962.03Cr.

What was the net profit for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2023?

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was ₹194.48Cr.

What was the net profit margin for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2023?

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was 20.22%.